Tonix Pharmaceuticals Holding Ratios (2023-2025) | TNXP

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 40.49%37.36%33.12%-52.49%44.90%54.18%61.18%-63.76%58.45%
EBT Margin -701.30%-723.00%-860.23%-3,501.54%-561.20%-870.64%-660.93%-1,384.78%-967.66%
EBIT Margin -705.62%-723.18%-860.23%-3,501.63%-551.17%-870.64%-660.93%-1,416.22%-1,005.08%
EBITDA Margin -705.62%-723.18%-860.23%-3,501.63%-551.17%-870.64%-660.93%-1,416.22%-1,005.08%
Operating Margin -705.62%-723.18%-860.23%-3,501.63%-551.17%-870.64%-660.93%-1,416.22%-1,005.08%
Net Margin -701.30%-723.00%-601.89%-3,567.75%-503.65%-856.24%-692.84%-1,415.02%-972.95%
FCF Margin -618.40%-631.69%-602.75%-712.45%-449.23%-666.55%-566.73%-682.79%-768.77%-904.07%
Efficiency
Inventory Average 13.52M13.49M13.01M10.91M8.69M8.17M8.27M7.06M5.86M
Assets Average 169.41M149.51M146.87M144.90M102.83M82.65M128.94M177.88M190.11M219.90M
Equity Average 152.94M130.65M113.18M106.83M75.12M58.16M106.88M159.98M174.20M199.57M
Invested Capital 165.43M140.46M120.83M116.53M116.09M49.34M80.75M148.21M180.40M168.00M231.14M
Asset Utilization Ratio 0.100.120.140.080.060.050.05
Leverage & Solvency
Interest Coverage Ratio -51.67
Debt to Equity 0.080.080.200.110.05
Debt Ratio 0.060.070.120.080.05
Equity Ratio 0.920.880.870.680.800.600.780.860.940.900.92
Times Interest Earned -51.67
Valuation
Enterprise Value -39.09M-9.28M2.77M-15.34M-2.61M-2.07M-24.97M-37.14M-16.69M138.21M21.73M
Market Capitalization 32.89M16.34M9.68M9.61M4.44M2.08M3.27M61.64M115.02M263.54M211.78M
Return Ratios
Return on Sales -12.36%-12.56%-13.57%-13.11%-8.34%-9.52%
Return on Capital Employed -1.91%-2.10%-1.24%-0.79%-0.48%-0.50%
Return on Assets -1.50%-1.72%-1.06%-0.74%-0.43%-0.45%
Return on Equity -2.05%-2.44%-1.28%-0.82%-0.47%-0.49%